{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:29:30Z","timestamp":1787502570814,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["C2024206032"],"award-info":[{"award-number":["C2024206032"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2022206011"],"award-info":[{"award-number":["H2022206011"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471066"],"award-info":[{"award-number":["32471066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171018"],"award-info":[{"award-number":["32171018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110565","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T02:35:51Z","timestamp":1750127751000},"page":"110565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pharmacological and electrophysiological characterization of the novel Kv7 channel inhibitor racecadotril in Parkinson's disease"],"prefix":"10.1016","volume":"278","author":[{"given":"Bo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0837-5356","authenticated-orcid":false,"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhuo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-6742","authenticated-orcid":false,"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110565_bib1","first-page":"277","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (vol 13, pg 1077, 2011), Europace","volume":"14","author":"Ackerman","year":"2012"},{"key":"10.1016\/j.neuropharm.2025.110565_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuropharm.2006.07.001","article-title":"The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels","volume":"51","author":"Bentzen","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110565_bib3","first-page":"168","article-title":"Kv7.2 subunit-containing M-type potassium channels in the lateral habenula are involved in the regulation of working memory in parkinsonian rats","author":"Bian","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110565_bib4","article-title":"The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in oocytes, plos one","volume":"4","author":"Blom","year":"2009"},{"key":"10.1016\/j.neuropharm.2025.110565_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","article-title":"Neural KCNQ (Kv7) channels","volume":"156","author":"Brown","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib6","article-title":"Dexmedetomidine can enhance PINK1\/Parkin- mediated mitophagy in MPTP-induced PD mice model by activating AMPK","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2025.110565_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-017-0177-3","article-title":"Potassium channels: a potential therapeutic target for parkinson's disease","volume":"34","author":"Chen","year":"2018","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2025.110565_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0028-3908(97)00155-X","article-title":"Inhibition of M-current in cultured rat superior cervical ganglia by linopirdine: mechanism of action studies","volume":"36","author":"Costa","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110565_bib10","doi-asserted-by":"crossref","DOI":"10.3791\/2609-v","article-title":"Measuring motor coordination in mice","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2025.110565_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2165\/11205950-000000000-00000","article-title":"Retigabine (ezogabine): in partial-onset seizures in adults with epilepsy","volume":"25","author":"Deeks","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2025.110565_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(93)90264-N","article-title":"Effects of the memory enhancer linopirdine (dup 996) on cerebral glucose metabolism in naive and hypoxia-exposed rats","volume":"620","author":"Dent","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110565_bib13","article-title":"Parkinson's disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Csh Perspect Med"},{"key":"10.1016\/j.neuropharm.2025.110565_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1460-9568.1990.tb00469.x","article-title":"Acetorphan, an enkephalinase inhibitor, modulates dopaminergic transmission in rat olfactory tubercle, but not in the nucleus accumbens and striatum","volume":"2","author":"Dourmap","year":"1990","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1476-5381.2011.01483.x","article-title":"Characteristics and molecular basis of celecoxib modulation on KV7 potassium channels","volume":"164","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00093","article-title":"A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril","volume":"3","author":"Eberlin","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0091-3057(94)90267-4","article-title":"Linopirdine (duP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission","volume":"49","author":"Fontana","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110565_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/molpharm.122.000640","article-title":"Modulation of Kv7 channel currents by echinocystic acid","volume":"104","author":"Geng","year":"2023","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib19","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1111\/bph.14823","article-title":"Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1","volume":"176","author":"Geng","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000289","article-title":"Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death","volume":"1","author":"Goldman","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2025.110565_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/jpet.117.241679","article-title":"XE991 and linopirdine are state-dependent inhibitors for Kv7\/KCNQ channels that favor activated single subunits","volume":"362","author":"Greene","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110565_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.115.231167","article-title":"Pharmacologic comparison of clinical neutral endopeptidase inhibitors in a rat model of acute secretory diarrhea","volume":"357","author":"Griggs","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110565_bib23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.106.106757","article-title":"The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat","volume":"318","author":"Hansen","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110565_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/aps.2013.79","article-title":"Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels","volume":"34","author":"Hu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2025.110565_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110565_bib27","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110565_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35036198","article-title":"Neuronal KCNQ potassium channels: physiology and role in disease","volume":"1","author":"Jentsch","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/jpet.108.147785","article-title":"KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle","volume":"329","author":"Joshi","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110565_bib30","article-title":"Site and mechanism of ML252 inhibition of Kv7 voltage-gated potassium channels","volume":"4","author":"Kanyo","year":"2023","journal-title":"Function (Oxf)"},{"key":"10.1016\/j.neuropharm.2025.110565_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","article-title":"The open field test for measuring locomotor activity and anxiety-like behavior","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib32","doi-asserted-by":"crossref","first-page":"22395","DOI":"10.1074\/jbc.M002378200","article-title":"Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity","volume":"275","author":"Lerche","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110565_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000527464","article-title":"Inhibition of Kv7\/M channel currents by fangchinoline","volume":"108","author":"Li","year":"2023","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2025.110565_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainresbull.2017.11.011","article-title":"The Kv7\/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease","volume":"137","author":"Liu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110565_bib35","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s12035-017-0486-6","article-title":"N-Propargyl caffeamide (PACA) ameliorates dopaminergic neuronal loss and motor dysfunctions in MPTP mouse model of Parkinson's disease and in MPP+-induced neurons via promoting the conversion of proNGF to NGF","volume":"55","author":"Luo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib36","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1038\/s41467-023-42416-x","article-title":"Ligand activation mechanisms of human KCNQ2 channel","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110565_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197946","article-title":"Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4\u2032I-MPP","volume":"13","author":"Mapa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110565_bib38","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1093\/brain\/awl239","article-title":"Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice","volume":"129","author":"Medja","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2025.110565_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0143-4179(90)90044-Y","article-title":"Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice","volume":"15","author":"Michael-Titus","year":"1990","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2025.110565_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0022-3565(25)39269-4","article-title":"Role of endogenous enkephalins in locomotion evidenced by acetorphan, an \"enkephalinase\" inhibitor","volume":"243","author":"Michael-Titus","year":"1987","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110565_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063231","article-title":"Comprehensive genetic screening of KCNQ4 in a large autosomal dominant nonsyndromic hearing loss cohort: genotype-phenotype correlations and a founder mutation","volume":"8","author":"Naito","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110565_bib42","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1440-1681.12958","article-title":"Effects of the Kv7 voltage-activated potassium channel inhibitor linopirdine in rat models of haemorrhagic shock","volume":"45","author":"Nassoiy","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/aps.2017.72","article-title":"Pharmacological modulation of the voltage-gated neuronal Kv7\/KCNQ\/M-channel alters the intrinsic excitability and synaptic responses of pyramidal neurons in rat prefrontal cortex slices","volume":"38","author":"Peng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2025.110565_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126681","article-title":"An anthrone-based Kv7.2\/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders","volume":"29","author":"Porter","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2025.110565_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1432102","article-title":"Characterizing the adult zebrafish model of Parkinson's disease: a systematic review of dynamic changes in behavior and physiology post-MPTP administration","volume":"18","author":"Razali","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib46","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/j.1460-9568.2004.03363.x","article-title":"Newly developed blockers of the M-current do not reduce spike frequency adaptation in cultured mouse sympathetic neurons","volume":"19","author":"Romero","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib47","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbrc.2008.02.152","article-title":"Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation","volume":"369","author":"Roura-Ferrer","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110565_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124190","article-title":"Quantitation of thiorphan in human plasma using LC-MS\/MS and its application to a bioequivalence study","volume":"1243","author":"Said","year":"2024","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib49","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0128-05.2005","article-title":"Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine","volume":"25","author":"Schenzer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib50","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0028-3908(01)00029-6","article-title":"KCNQ4 channel activation by BMS-204352 and retigabine","volume":"40","author":"Schroder","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110565_bib51","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1523\/JNEUROSCI.5017-05.2006","article-title":"Structural determinants of M-type KCNQ (Kv7) K+ channel assembly","volume":"26","author":"Schwake","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib52","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1124\/mol.106.026625","article-title":"Enhancement of hippocampal pyramidal cell excitability by the novel selective slow-afterhyperpolarization channel blocker 3-(triphenylmethylaminomethyl)pyridine (UCL2077)","volume":"70","author":"Shah","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/mol.110.066100","article-title":"The specific slow afterhyperpolarization inhibitor UCL2077 is a subtype-selective blocker of the epilepsy associated KCNQ channels","volume":"78","author":"Soh","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110565_bib55","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110565_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1113\/jphysiol.2006.112888","article-title":"Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential","volume":"576","author":"Wangemann","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1113\/jphysiol.2006.113308","article-title":"KCNQ\/M-currents contribute to the resting membrane potential in rat visceral sensory neurons","volume":"575","author":"Wladyka","year":"2006","journal-title":"J Physiol-London"},{"key":"10.1016\/j.neuropharm.2025.110565_bib59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1124\/mol.104.010793","volume":"67","author":"Wuttke","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110565_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2007.11.010","article-title":"Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds","volume":"29","author":"Xiong","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110565_bib61","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1096\/fj.201802848RR","article-title":"Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J."},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2025.110565_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000505934","article-title":"Antinociceptive efficacy of retigabine and flupirtine for gout arthritis pain","volume":"105","author":"Zhang","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2025.110565_bib63","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1476-5381.2012.02232.x","article-title":"Modulation of KV7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58","volume":"168","author":"Zhang","year":"2013","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:21:39Z","timestamp":1779614499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":61,"alternative-id":["S0028390825002710"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110565","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and electrophysiological characterization of the novel Kv7 channel inhibitor racecadotril in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110565"}}